Cagrilintide: What It Is and How It's Being Studied for Weight Loss In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Clinical trials of subcutaneous tirzepatide, retatrutide, and Download Scientific Diagram CagriSema vs Tirzepatide: Amylin GLP 1 vs GIP GLP 1 for Maximum Weight Loss Which Is Better? PPW Peptide Protocol Wiki Comparing the Big 3, Semaglutide, Tirzepatide and Retatrutide : r Mounjaro Full article: Pharmacotherapy for Obesity: Recent Updates